New York City, DC out of monkeypox vaccine

newYou can now listen to Fox News articles!

Want Monkeypox Vaccines The supply is being overtaken in New York City and Washington, D.C., which are two of the first cities in the US to offer vaccinations against the virus.

The DC Health Department announced that 300 appointments for the monkeypox vaccine would be available on Tuesdays and Thursdays, but those locations were booked by Monday afternoon.

New York City also began offering the Xynos vaccine at the Chelsea Sexual Health Clinic, but by Monday all appointments were filled.

The Bavarian Nordic is the only one in the world approved for a smallpox vaccine called Geneos in the US and Imvanex in Europe, which is also effective against monkeypox.

The Bavarian Nordic is the only one in the world approved for a smallpox vaccine called Geneos in the US and Imvanex in Europe, which is also effective against monkeypox.
(Reuters/Lucas Barth)

In both New York City and DC, eligibility was limited to gay and bisexual men, as they are disproportionately affected by monkeypox. DC was also giving Vaccine sex workers and employees of the establishment where sexual activity takes place.

Biden admin promotes testing for monkeypox

New York City has reported at least 48 cases of monkeypox, while DC has reported 16 cases.

Health officials said earlier this month that the US government had 72,000 doses of Jynneos vaccine in its stockpile.

In this handout graphic from the Centers for Disease Control and Prevention, symptoms of one of the first known cases of monkeypox virus are shown on the arm of a patient.

In this handout graphic from the Centers for Disease Control and Prevention, symptoms of one of the first known cases of monkeypox virus are shown on the arm of a patient.
(CDC/Getty Images)

The Jynneos vaccine is a two-dose regimen that is administered at four-week intervals. A person is fully vaccinated after the second dose.

Click here to get Fox News App

There are about 100 million doses of the old smallpox vaccine, ACAM2000, in the US, but it has potentially serious side effects and CDC officials say there will be “serious discussions” before using it.

The Associated Press contributed to this report.